Medical Devices Startups

AdipoPharma is a French biotech company developing PATAS, a first-in-class stapled peptide insulin sensitizer that targets adipocytes to treat insulin resistance, type 2 diabetes, and associated comorbidities. Its adipocyte-focused approach aims to address the root cause of type 2 diabetes, with its lead drug entering clinical trials in 2025.

2 investors

Adiposs develops ImageBAT, a contrast agent for medical imaging of brown fat that can identify patients at increased cancer risk and with higher treatment failure risk. The product serves oncology and metabolic health markets.

2 investors

Adravision builds a shared intelligence platform that integrates fragmented dental information systems, connecting clinical records, radiographs, treatment plans, and insurance data to support care delivery, documentation, and reimbursement.

2 investors

adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing. It serves medical device developers seeking to accelerate R&D and reduce clinical trial risk.

2 investors

QScout Lab provides rapid, on-farm diagnostic tests for livestock producers to detect diseases and guide treatment decisions. The company offers tests like QScout® BLD for beef cattle and QScout® MLD for dairy cattle to detect infections early and optimize antibiotic use.

2 investors

Aeronics develops portable oxygen storage systems that use advanced materials to store oxygen more efficiently than traditional high-pressure cylinders, producing lighter systems for consumer, veterinary, and medical applications. Its Pawprint Oxygen product line provides portable oxygen therapy kits for pets, used by veterinary hospitals and pet owners.

2 investors

Affera develops a medical technology platform for treating cardiac arrhythmias, including atrial fibrillation, using innovative ablation solutions. The company serves cardiac electrophysiology specialists and healthcare systems treating arrhythmia patients.

2 investors

aflo is a digital health platform that automates and corrects inhaler technique for patients with asthma and COPD, combining daily inhalation scores with air quality and behavior data to improve symptom control. It targets both patients and clinicians managing respiratory conditions, aiming to reduce technique errors, healthcare costs, and the carbon footprint of metered dose inhalers.

2 investors

Africa Healthcare Network operates a chain of dialysis clinics across Sub-Saharan Africa, delivering dialysis treatment at affordable cost. It combines technical expertise with local operating experience to serve patients needing kidney care in the region.

2 investors

Agios is a biopharmaceutical company developing therapies for rare diseases, with a primary focus on hemolytic anemias including pyruvate kinase deficiency, thalassemia, and sickle cell disease. The company's approach is grounded in cellular metabolism research and involves close collaboration with patients and clinical partners.

2 investors

Aidar (Aidar Health) develops digital medicine solutions that combine physical and digital biomarkers with predictive algorithms to support precision medicine and remote patient monitoring. Its offerings serve healthcare providers, life sciences companies, and payers, targeting areas such as long-term care, clinical trials, and population health management.

2 investors

Aidence, founded in 2015 in Amsterdam, was a radiology AI company that built clinical applications to help radiologists and physicians interpret medical images, focused on pulmonary nodule management and lung cancer screening. Its main product, Veye Lung Nodules (now DeepHealth Lung), was a CE-marked AI solution for lung nodule detection, classification, quantification, and growth assessment; the company was acquired by RadNet in 2022 and integrated into DeepHealth.

2 investors

Airsonett develops the Air4, a CE-marked Class 1 medical device that uses patented Temperature-controlled Laminar Airflow (TLA) to deliver clean, allergen-free air around a patient's face during sleep for home treatment of allergic asthma and atopic dermatitis. It serves patients with allergic diseases, primarily in Sweden and the UK.

2 investors

Aitiologic is a molecular diagnostics and precision medicine company that uses AI-powered bioinformatics to translate disease biology into clinical insight. It operates in the biotech and diagnostics space.

2 investors

Aivero develops Orvue, a single-use robotic camera for laparoscopy that lets surgeons control the camera directly instead of relying on manual handling. The device targets surgical procedures and is built as a platform intended to capture and use procedure data.

2 investors

AK Medical (爱康医疗) develops orthopedic implants and technologies, including metal 3D-printed implants with trabecular bone-like structures, Supravit HA plasma vacuum spray coatings, surgical planning software and robotics, and personalized custom orthopedic solutions. It serves surgeons and clinical orthopedic care with implant product systems and instrument sets.

2 investors

Akamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life. The company serves patients and clinicians in the oncology market.

2 investors

Akebia Therapeutics develops FDA-approved drug therapies for the treatment of kidney disease. The company is a fully integrated biopharmaceutical organization with a nephrology-focused commercial team and development capabilities.

2 investors

2 investors

Akridata builds AI-powered visual inspection systems for quality control and defect detection across manufacturing, medical devices, automotive, and critical infrastructure. The platform combines computer vision and machine learning to automate inspection processes, reduce defects, and optimize production workflows.

2 investors

Alchemy Health publishes a state-by-state tracker of the federal Rural Health Transformation Program (RHTP), summarizing each state's funding allocation, current and upcoming funding opportunities, and engagement events. The resource is aimed at organizations serving people living with HIV, hepatitis C, and other infectious diseases in rural communities.

2 investors

Alcon develops eye care products and medical technologies, including the Valeda Photobiomodulation (PBM) system for retina treatment, for eye care professionals such as retina specialists.

2 investors

Alcresta Therapeutics develops enzyme-based therapeutic products to address nutritional care for enterally fed patients living with rare diseases. The company is based in Massachusetts and focuses on delivering novel enzymatic solutions within the biotechnology and pharmaceutical sector.

2 investors

Alertgy develops a non-invasive wristband device for real-time blood glucose monitoring in diabetics using Deep-Gluco sensor technology. The product targets both individual patients and healthcare providers.

2 investors